Pro Medicus Ltd

PME

Company Profile

  • Business description

    Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

  • Contact

    450 Swan Street
    RichmondVIC3121
    AUS

    T: +61 394298800

    https://www.promed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    30 June 2025

    Employees

    75

Pro Medicus Ltd News & Analysis

stocks

Have big earnings season moves made way for opportunities?

We look at the biggest market reactions in our coverage and what our analysts think about the companies.
stocks

ASX earnings recap from last week

We heard from some of the heavy weights in the ASX 200 including CBA and CSL.
stocks

ASX growth darling wows again but looks expensive

Pro Medicus reported another strong set of results. It continues to trade at a lofty valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,633.1066.100.77%
CAC 407,255.0141.690.58%
DAX 4019,322.59176.420.92%
Dow JONES (US)44,296.51426.160.97%
FTSE 1008,262.08112.811.38%
HKSE19,229.97371.14-1.89%
NASDAQ19,003.6531.230.16%
Nikkei 22538,283.85257.680.68%
NZX 50 Index13,041.90276.662.17%
S&P 5005,969.3420.630.35%
S&P/ASX 2008,393.8070.800.85%
SSE Composite Index3,267.19103.21-3.06%

Market Movers